S
Synklino
Biotech & Life Sciences · Copenhagen, Denmark · Founded 2017
Strives to provide rapid relief and improve long-term survival for transplant recipients by providing fast and safe eradication of cytomegalovirus (CMV) infections MoreLess
Synklino is a biotechnology company focused on developing innovative treatments to eliminate cytomegalovirus (CMV) infections in transplant recipients. Operating in the healthcare and biotech market, Synklino serves patients who have undergone organ and stem cell transplants, providing them with a crucial safeguard against CMV, which can be devastating post-transplant. The company's business model revolves around the research, development, and commercialization of its proprietary treatments, generating revenue through the sale of these specialized medical solutions. By ensuring the elimination of CMV infections, Synklino helps patients recover faster and maintain their quality of life post-transplant.
Keywords: biotechnology, CMV, transplant, healthcare, innovation, treatment, quality of life, infection prevention, medical solutions, commercialization.
Company overview
Synklino company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Copenhagen, Denmark
- Employees
- 14
- Open positions
- 1
- Dealroom signal
- 75.8
Valuation & funding
Synklino funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Jul 2023 | $332K | — | Horizon Europe | — |
| SERIES AOther financing | Jun 2022 | $33M | $131M | Eir Ventures · PKA | ↗ |
| EARLY VCOther financing | Dec 2021 | $15M | $62M | Eir Ventures | ↗ |
| SEEDOther financing | Sep 2020 | — | — | Eir Ventures | — |
| CONVERTIBLEOther financing | Aug 2019 | $1.5M | — | BioInnovation Institute | ↗ |
| SPINOUTOther financing | Dec 2017 | Technical University of Denmark | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 14 |
| 2025 | 13 |
| 2024 | 16 |
| 2023 | 26 |
| 2022 | 24 |
| 2021 | 15 |
| 2020 | 11 |
Growth signals
Synklino website traffic
Latest recorded traffic for Synklino is 120 monthly website visits, up 140% over the last three months. Synklino's team grew 7.7% over the past year.
Comparisons
Synklino compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Synklino's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Synklino's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Synklino has talent and traffic
team presence
In the news
Latest news about Synklino
Recent press, funding announcements, and product moves mentioning Synklino — open to read from the original sources.
Market sentiment
What the market is saying about Synklino
An AI-synthesized read of the highest-engagement posts about Synklino on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Synklino’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.